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Eight out of 10 breast cancer patients die within 5 years after the
primary tumor has spread to the bones. Tumor cells disseminated
from the breast roam the vasculature, colonizing perivascular niches
around blood capillaries. Slow flows support the niche maintenance
by driving the oxygen, nutrients, and signaling factors from the
blood into the interstitial tissue, while extracellular matrix, endothe-
lial cells, and mesenchymal stem cells regulate metastatic homing.
Here, we show the feasibility of developing a perfused bone
perivascular niche-on-a-chip to investigate the progression and drug
resistance of breast cancer cells colonizing the bone. The model is a
functional human triculture with stable vascular networks within a
3D native bone matrix cultured on a microfluidic chip. Providing the
niche-on-a-chip with controlled flow velocities, shear stresses, and
oxygen gradients, we established a long-lasting, self-assembled
vascular network without supplementation of angiogenic factors.
We further show that human bone marrow-derived mesenchymal
stem cells, which have undergone phenotypical transition toward
perivascular cell lineages, support the formation of capillary-like
structures lining the vascular lumen. Finally, breast cancer cells
exposed to interstitial flow within the bone perivascular niche-on-
a-chip persist in a slow-proliferative state associated with increased
drug resistance. We propose that the bone perivascular niche-on-
a-chip with interstitial flow promotes the formation of stable
vasculature and mediates cancer cell colonization.
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Disseminated tumor cells can emerge as bone metastases af-ter years or decades of latency, killing breast cancer patients
(1, 2). Elucidating the cellular mechanisms and the role of the
tumor microenvironment in regulating this latency is crucial for
improving survival rates through targeted therapy. Recent evi-
dence shows that cancer cells escaping the vasculature colonize
specific niches around blood capillaries in the bone marrow—
known as perivascular niches (3). Here, the endothelium, stem
cells, and the extracellular matrix (ECM) modulate cancer cell
survival. Slow flows driving oxygen, nutrients, and signaling fac-
tors from the blood vessels into the interstitial tissue are key
players in the niche maintenance (4). While in vivo models have
helped identify tumor cells residing in the perivascular niches,
manipulating the host microenvironment to study the contribu-
tion of niche components remains challenging (5). Using engi-
neering techniques, the cells, ECM, and biophysical signals can
be controlled in vitro. For example, endothelial cells (ECs)
mixed with stromal cells in a 3D hydrogel provided insights on
how vascular sprouts mediate breast cancer growth (6). Similar
systems can be matured on microfluidic chips to form tissues
with organ-like features—also known as organs-on-a-chip. Cru-
cial steps of tumor angiogenesis, migration, and extravasation
have been successfully recapitulated using these models (7–10).
However, one main limitation of the existing models is the need
for high concentrations of growth and angiogenic factors to
promote vascular sprouting. In the growth-promoting milieu, it is
challenging to mimic early metastatic events and cancer latency
because of unchecked cancer cell proliferation. Most of the
previously established models rely on passive diffusion of mole-
cules, whereas flows in vivo regulate the balance between nu-
trient supply and metabolite removal. Soft hydrogels are highly
effective in promoting vascular formation but fail to mimic the
stiffness and biochemical composition of native bone niche.
Here, we addressed some limitations of the existing models by de-
veloping a bone perivascular (BoPV) niche-on-a-chip incorporating
interstitial flow to investigate breast cancer metastatic colonization
and drug resistance. To establish the model, human endothelial and
bone marrow-derived mesenchymal stem cells (MSCs) were cul-
tured in a native bone matrix and placed into a microfluidic chip,
where cells were exposed to fluid flow. By infusing breast cancer
cells, we mimicked metastatic colonization using a functional hu-
man triculture system. Exposing cells to physiologically relevant flow
velocities and oxygen gradients, we achieved a long-lasting, self-
assembled microvascular network without continuous supplemen-
tation of angiogenic factors. The phenotypical transition of MSCs
toward mural cell lineages supported the formation of capillary-like
structures in the niche. Finally, disseminated breast cancer cells
exposed to flow exhibited a slow-proliferative state and increased
drug resistance in the BoPV niche-on-a-chip model.
Results
Three-Dimensional Vascular Networks in Bone. Despite advances in
modeling cancer metastasis, the maintenance of vascular net-
works in vitro still requires continuous use of specialized culture
mediums. Under these conditions, cancer cells are forced to
grow regardless of the niche signaling. We hypothesized that
Significance
Improved human preclinical models are needed to better predict
patients’ responses to anticancer drugs. Increasing the complexity
of models may be a successful strategy only if crucial components
of a tumor are identified, replicated, and controlled in vitro. We
developed a perivascular niche to study metastatic colonization
of the bone. Using a microfluidic chip, we exposed the niche to
interstitial flow, oxygen gradients, and external forces, and
established a dense vascular network. Cancer cells colonizing the
bone resisted targeted therapy by entering a slow proliferative
state. We expect that microfluidic niche-on-chip models will fa-
cilitate the development of drugs targeting persistent tumor cells
into the bone and help manage the risk of metastatic relapse.
Author contributions: A.M.-K. and G.V.-N. designed research; A.M.-K., M.M.N., K.Y., A.C.,
L.H., S.R., and E.G. performed research; A.M.-K., M.M.N., and G.V.-N. analyzed data; and
A.M.-K., M.T.R., and G.V.-N. wrote the paper.
The authors declare no conflict of interest.
This article is a PNAS Direct Submission.
Published under the PNAS license.
1To whom correspondence may be addressed. Email: manuela.raimondi@polimi.it or
gv2131@columbia.edu.
This article contains supporting information online at www.pnas.org/lookup/suppl/doi:10.
1073/pnas.1714282115/-/DCSupplemental.
1256–1261 | PNAS | February 6, 2018 | vol. 115 | no. 6 www.pnas.org/cgi/doi/10.1073/pnas.1714282115
using a 3D bone scaffold, with the preserved native biochemical
and biophysical composition, will support the formation of stable
microvasculature without high concentrations of angiogenic or
growth factors commonly needed in vitro. To test this hypothesis,
we seeded fluorescently labeled ECs mixed with MSCs into
decellularized 3D bone matrix and two controls: 2D (monolayer)
and 3D polystyrene (commonly used plastic for cell culture
dishes). Bone decellularization was carried out before repopu-
lating the matrix with human cells. To demonstrate effectiveness
of the decellularization protocol, we measured the DNA content
of the bone before and after decellularization (430.6 ± 150 and
7.3 ± 1.5 ng of DNA per mg of tissue’s wet weight, respectively)
(SI Appendix, Fig. S1A). A micro-computed tomography (μ-CT)
scan showed the retention of the mineralized trabecular struc-
ture while all cellular material was removed (SI Appendix, Fig.
S1B). To document the maintenance of ECM components, we
measured the milligrams of hydroxyapatite per unit volume
(tissue mineral density), within the ranges reported for humans
(SI Appendix, Fig. S1C) (11). The trabecular voids were filled
with the MSCs–ECs coculture and maintained for 1 wk in en-
dothelial medium (EM) followed by 1 wk in serum-reduced
medium (SRM) (Fig. 1 A and B). Controls were maintained in
EM for 14 d. Using live confocal imaging, we measured vascular
formation and quantified vessel density, number of junctions, total
vessel length, average vessel length, and number of endpoints (Fig.
1 C and D and SI Appendix, Fig. S2 A–D). ECs maintained in
SRM in 2D and 3D polystyrene cultures generated shorter vessels
compared with those grown in EM. In the bone matrix, ECs failed
to organize vascular connections when maintained in EM for 2 wk.
Switching to SRM after the first week of culture induced the
formation of vascular networks with increased branching, number
of junctions, and total and average vessel length. By analyzing the
mRNA levels of genes involved in vasculogenesis, we found in-
creased TSP1, VEGFR1, VEGFR2, POSTN, and Survivin expres-
sion in cells cultured in SRM (Fig. 1E). We observed higher
VEGFR1, VEGFR2, POSTN, and lower TSP1 expression in the
coculture compared with the MSCs-only culture. However, in the
absence of flow, vascular networks were confined to the outer
edges of the bone and relied on diffusional mass transport only.
Microfluidic Niche-on-a-Chip. Because the MSCs–ECs cultured
statically formed vascular networks only at the outer edges of the
bone matrix, we investigated whether physiologically relevant
interstitial flow would support the formation of vascular net-
works throughout the bone tissue. To this end, the tissues were
placed into the microfluidic chip, cultured in SRM, and exposed
to controlled flow velocities for 1 wk to form the BoPV niche-on-
a-chip (Fig. 1F). The perfusion chambers of the chip supported
three independent samples. The chambers were sealed by plac-
ing a glass coverslip on top of the flow gasket and secured using
Fig. 1. Formation and maintenance of the niche-on-a-chip. (A) Generation of the bone perivascular (BoPV) niche for studies of breast cancer colonization.
Human bone marrow-derived mesenchymal stem cells (MSCs) and endothelial cells (ECs) were cultured in monolayers and in 3D decellularized bone matrix.
Culture regimen involved 1 wk in endothelial medium (EM) followed by 1 wk in serum-reduced medium (SRM), or 2 wk in EM. After 1 wk of static culture, cancer
cells were infused into the bone tissue, and perfusion was initiated in the microfluidic chip. (B, Top) Bone tissue reconstruction based on micro-computed to-
mography (μ-CT) data. (Bottom) Rectangular-shaped bone matrix in the microfluidic chip. (C) Confocal images of RFP-labeled ECs forming vascular networks in
monolayers or in the bone matrix. (Scale bar: 200 μm.) (D) Quantification of neovessel formation using confocal images. Vessel density (VD), number of junctions
(NJ), branching index (BI), total vessel length (TVL), average vessel length (AVL), and number of endpoints (EP) were measured after 2 wk of culture and nor-
malized to day 3 values. (E) Gene expression of MSCs-only or MSCs-plus-ECs cultures in the bone matrix. mRNA levels were normalized to the gene expression
levels after 2 wk of culture in EM. (F) Overview of the microfluidic chip used to culture the BoPV niche. (G) Immunostaining of endothelial marker CD31 in the
BoPV niche-on-a-chip, showing capillary-like structures (arrowheads) filling the trabecular pores (green asterisk) in the preexisting bone trabeculae (red asterisks).
(Scale bar: 50 μm.) Data in D and E are represented as average + SD; *P < 0.05; **P < 0.01; ***P < 0.001; unpaired two-tailed Student’s t test.
























magnetic clamps. The device is optically accessible, allowing
assessment of cell/tissue outcomes in real time. Syringes con-
taining fresh culture medium were connected to the inlet loop
through bubble traps, and a glass container was used to collect
waste medium (SI Appendix, Fig. S2E and Movie S1). Immu-
nohistochemistry showed that, after 2 wk of culture, MSCs and
ECs populated the trabecular space. CD31-negative MSCs cells
lined the bone trabeculae promoting tissue integration with the
existing mineral matrix, whereas CD31-positive ECs formed
capillary-like structures within the trabecular pores (Fig. 1G).
Optimization of Interstitial Flow Velocities and Shear Forces. In-
terstitial flows within 0.1–5 μm·s−1 enable nutrient supply in vivo
and impart extracellular forces on cells regulating tissue mor-
phogenesis (4). To finely tune the perfusion flow within the
BoPV niche, we used a computational fluid dynamics (CFD)
approach (Fig. 2A and Movie S2). To account for the complex
geometrical features of trabecular bone, we imported the μ-CT
of the bone scaffold in the CFD software (SI Appendix, Fig. S3 A
and B, and Table S1). In the computational model, we tested
several flow rates and found that 0.25 μL·min−1 flow rate
resulted in an average fluid velocity of ∼3.1 μm·s−1 within the 3D
bone matrix (Fig. 2B). To validate the CFD analysis, fluorescent
microbeads were perfused through the bone tissue at different
flow rates (Fig. 2C and Movies S3 and S4). The microbead dis-
placement across frames was recorded using a fluorescent mi-
croscope and analyzed using micro-particle image velocimetry
(μ-PIV) software. No significant difference was found between
the CFD-predicted and the μ-PIV–measured velocity values,
suggesting that the computational analysis accurately pre-
dicted the fluid dynamics in the 3D structure (Fig. 2D). The
0.25 μL·min−1 resulting in an average interstitial fluid velocity
of ∼3.1 μm·s−1 was used in all of the following experiments,
unless specified otherwise. Because specific thresholds of fluid-
derived shear forces can drive cellular responses including endo-
thelial sprouting, cancer cell migration, and growth inhibition (12,
13), we used the CFD to estimate the shear stress acting on the
bone tissues at different flow velocities (Fig. 2 E and F). The shear
stresses estimated for 0.25 μL·min−1 ranged between 0.03 and
0.32 mPa, and peaks of force were observed in areas with higher
flow velocities (Fig. 2G and SI Appendix, Fig. S4). Our computa-
tional and experimental approach enabled fine-tuning of flow
Fig. 2. Flow velocity, shear stress, and oxygen profiles in the BoPV niche-on-a-chip. (A) Color maps showing bone μ-CT scans imported in a CFD software for
the prediction of flow velocities and shear stresses at an inlet flow rate of 0.25 μL·min−1. (Scale bar: 1 mm.) (B) Color maps of the flow velocity at low (Top) and
high magnification (Bottom). (Scale bar: 1 mm.) (C) Validation of the CFD-predicted flow velocities, using fluorescent microspheres suspended in culture
medium and perfused through the bone tissue. The microspheres were tracked and the average flow velocity was calculated using micro-particle image
velocimetry (μ-PIV) software. (Scale bar: 50 μm.) (D) Comparison of the measured (μ-PIV) and CFD-predicted velocities in the bone matrix at different inlet flow
rates. An inlet flow rate of 0.25 μL·min−1 resulted in an interstitial fluid velocity of ∼3.1 μm·s−1. (E) Color maps of the shear stress in the bone matrix. (Scale bar:
1 mm.) (F) Shear stress magnitude in the bone tissue at different inlet flow rates. (G) Histogram of the shear stress magnitude and frequency in the perfused
BoPV niche at an average velocity of ∼3.1 μm·s−1. (H and I) Estimated oxygen consumption (H) and concentration (I) in the BoPV niche after 2 wk of culture.
Color maps in isometric view (Top) and top view (Bottom). (Scale bar: 1 mm.) (J) Predicted oxygen depletion in the BoPV niche at week 2, a function of the
distance from the flow inlet and the flow velocity (∼3.1 μm·s−1). (Scale bar: 3 mm.) Data in D and F are shown as average + SD; n = 3.
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rates in the microfluidic device to achieve controlled interstitial
flow velocities within the niche-on-a-chip.
Flow-Controlled Oxygen Concentration Profiles. Oxygen gradients
regulate stem cell homing and cancer progression in the bone
(14, 15). Using a computational analysis that has been validated
by previously reported experimental measurements (16), we
studied how flow velocities regulated oxygen profiles in the
BoPV niche-on-a-chip. The perfusion chamber was designed to
force medium flow through the front (inlet) and the back (outlet)
surface of the rectangular bone tissue (Fig. 2 H and I). The
gradients in the perfused tissue model resulted from the diffusive
and convective transport of oxygen coupled to its consumption
by cells. In the perfused niche, oxygen concentration decreased
along the scaffold length, in the direction of flow. An interstitial
velocity of ∼3.1 μm·s−1 resulted in a steep decrease in oxygen
concentrations of 75% across the length of the tissue (Fig. 2J).
As expected, higher flow rates resulted in shallower gradients,
due to the increased oxygen supply at relatively unchanged cellular
consumption. Controlled perfusion, mimicking native interstitial
flow, was critical for the transport of nutrients, metabolites, and
oxygen throughout the tissue volume.
BoPV Niche-on-a-Chip with Interstitial Flow. Immunostaining showed
that interstitial flow (∼3.1 μm·s−1) promoted new tissue formation
and the sprouting of capillary-like structures (Fig. 3A). In perfused
cultures, we measured increases in cell numbers after 14 d in the
chip (SI Appendix, Fig. S5A). The RFP-labeled ECs cultured with
the MSCs and exposed to interstitial flow formed a densely inter-
connected network of vessels running through the tissue (Fig. 3B).
Significant increases in vessel density, number of junctions,
branching, and total vessel length, were measured in the perfused
niches, supporting our hypothesis that physiologically relevant flow
promotes the formation of a stable 3D microvasculature (Fig. 3C,
SI Appendix, Fig. S5B, and Movie S5). Gene expression analysis
demonstrated that cells exposed to flow had increased mRNA
levels of the proangiogenic POSTN (periostin) and antiapoptotic
Survivin markers (Fig. 3D). qRT-PCR performed on a mixed
Fig. 3. Flow promotes vasculogenesis in the BoPV niche-on-a-chip. (A) Top view and cross-section of hematoxylin and eosin staining, showing newly formed
tissue and capillary-like structures filling the trabecular spaces in the BoPV niche cultured statically or with interstitial flow (3.1 μL·s−1). (Scale bar: 250 μm.)
Composite images were obtained by capturing and stitching high-magnification images. (B) Live confocal images showing RFP-labeled ECs in the BoPV niche
and the static controls, after 2 wk of culture. (Scale bar: 350 μm.) (C) Quantification of vessel density (VD), number of junctions (NJ), branching index (BI), total
vessel length (TVL), average vessel length (AVL), and number of endpoints (EP). Values were normalized to day 3. (D) Gene expression analysis; values were
normalized to the static culture. (E) Immunofluorescence staining showing periostin deposited in the BoPV niche-on-a-chip. (Scale bar: 10 μm.) (F) Immu-
nohistochemical analysis of perivascular markers in the static culture or in the BoPV niche-on-a-chip. Black arrowheads highlight the capillary-like lumens.
(Scale bar: 100 μm.) Data in C and E are represented as average + SD; n = 6; *P < 0.05, **P < 0.01, ***P < 0.001, unpaired two-tailed Student’s t test.
























population of cells can give informative insights on the overall
expression and not on the contribution of a single population of
cells. However, immunofluorescence confirmed the secretion of
periostin within the pores of the bone matrix (Fig. 3E). Periostin
was not observed only in the proximity of RFP-expressing ECs,
suggesting secretion byMSCs. Immunohistochemical staining showed
that cells expressing the perivascular markers CD146, NG2, or
PDGF-Rβ lined the vascular lumens and supported the formation of
capillary-like structures (Fig. 3F). Overall, interstitial flow promoted
cell proliferation and the formation of uniformly dense vascular
networks, with cells forming capillary-like structures that expressed
endothelial and perivascular markers.
Metastatic Colonization of the BoPV Niche-on-a-Chip. To simulate
metastatic colonization, 250 breast cancer cells were introduced
into each BoPV niche-on-a-chip and perfused, establishing a
human triculture system. Using confocal microscopy, we tracked
GFP-labeled MDA-MB-231 breast cancer cells and the RFP-
labeled ECs (Fig. 4A and Movie S6). In static cultures, the cells
formed only sparse vascular networks. In perfused cultures, the
same cells self-assembled into dense vascular networks even in
the presence of cancer cells. We observed a reduced number of
cancer cells in the perfused niche after 1 wk of culture (Movie
S7). To confirm this observation, breast cancer cells—expressing
luciferase or GFP reporter gene—were cultured alone (C), with
MSCs (C+M), or with MSCs and ECs (C+M+E) in the bone
matrix, under flow or in static conditions. By quantifying the
tumor cell area fraction normalized to day 7, we measured a
fourfold decrease in cancer cell growth rate in perfused cultures
(Fig. 4B). Using a luminescence assay, we supported these results
(Fig. 4C). We confirmed that the reduction in cell concentration
was not due to the cell loss into the flow. Instead, these results
suggest that physiologically relevant interstitial flow triggered a
slow-proliferative state in breast cancer cells colonizing the
niche. Next, we investigated whether the receptor tyrosine kinase
inhibitor sunitinib, commonly used to target proliferative cancer
cells and vasculature, was effective in the BoPV niche-on-a-chip
colonized by breast cancer cells. The drug concentration was set
to 3.5 μM, the value corresponding to the half-maximal in-
hibitory concentration (IC50) of sunitinib measured in monolayer
cultures of breast cancer cells (SI Appendix, Fig. S5C). Cancer
cell growth was inhibited by 50% following drug treatment in the
absence of flow (Fig. 4D). Conversely, slow-proliferative cancer
cells in the perfused niche were less sensitive to sunitinib treat-
ment. There was no significant drop in cell number between
sunitinib-treated and vehicle controls. Notably, we found that
fluid flow in the BoPV niche-on-a-chip impaired growth and
desensitized cancer cells to commonly used drugs. Overall,
cancer cells colonized the BoPV niche-on-a-chip adapting to
flow, ECM, and stromal cells. MSCs, mural cells, and ECs
populated the niche and mediated metastatic homing. Antican-
cer drugs, targeting proliferating cancer cells and tumor vascu-
lature, failed to affect the slow-proliferative cancer cells that
were adapting and surviving in the niche (SI Appendix, Fig. S6).
Discussion
Microfluidic models aim to reconstitute functional units of or-
gans that cannot be modeled easily in cell cultures or animals. In
the context of cancer metastasis, these functional units can be
conceived as niches where disseminated tumor cells colonize
after extravasating the vascular route. By developing a BoPV
niche-on-a-chip, we attempted to integrate some of the critical
components of the metastatic cancer niche to model coloniza-
tion. Our strategy differs from the well-established methodolo-
gies of culturing ECs with stromal cells on soft hydrogels, such as
Matrigel or fibrin. Under these conditions, and in the presence
of proangiogenic and progrowth mixtures, ECs form dense
microvasculature. However, mimicking metastatic colonization
under growth-promoting conditions may be misleading because
cancer cells are constantly forced into highly proliferative states.
Using a 3D bone matrix with its native features, we maintained
EC viability and branching without the need of specialized cul-
ture mediums. While many of the culture systems used in pre-
vious studies were microfluidic in the sense that the channels
used to insert and host the cells were of microscopic thickness,
the culture medium and hydrogels carrying the cells were
inserted into the device and maintained in nonperfused culture
(17). Under nonperfused conditions, both the convective trans-
port of soluble factors to cells and fluid-dynamic stimulation of
the cells are absent. Thus, progressive oxygen drop and meta-
bolic waste accumulation are not controlled, while important
paracrine signals released by cells may reach only small distances
due to diffusion barriers. To overcome these issues, flow veloc-
ities in the chip were adjusted using a computational model and
Fig. 4. Breast cancer cells colonization in the BoPV niche-on-a-chip. (A) Live
confocal images of breast cancer cells (GFP-transduced MDA-MB-231 cells) in
the BoPV niche with interstitial flow (∼3.1 μm·s−1; Bottom). (Scale bar: 50 μm.)
(B) Tumor cell area fraction of GFP MBA-MB-231 breast cancer cells at days
10 and 14 in MSCs-only (C+M) or MSCs–ECs coculture (C+M+E) exposed to
interstitial flow or cultured statically (no flow). Values were normalized to day
7 (1 d after cancer cells seeding). (C) Luciferase assay used to measure breast
cancer cell growth within the bone niches containing only cancer cells (C),
MSCs-only (C+M), or MSCs and ECs (C+M+E). Values were normalized to the
luciferase signal at day 7 (1 d after cancer cells seeding into the tissue con-
structs). (D) The BoPV niches, infused with breast cancer cells, were treated
with 3.5 μM sunitinib for 3 d. Luciferase assay was used to measure cancer cells
survival. Values were normalized to the luciferase activity of tissue constructs
treated with the drug vehicle (control). (D) Data in B–D are shown as average +
SD; n = 5; *P < 0.05, ***P < 0.001; unpaired two-tailed Student’s t test.
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maintained at physiologically relevant levels (18). In addition,
shear forces, which are crucial for tissue morphogenesis and
vascular sprouting, depend on flow velocity and niche topology
(4, 19). In vivo measurements of oxygen tension have shown the
presence of steep oxygen gradients in the bone marrow, where
arteries carry oxygen, nutrients, and growth factors into the in-
terstitial space, before feeding into sinusoids, to form the venous
circulation. In our chip, we mimic this function and show that
similar oxygen gradients form in the direction of perfusion flow
in the bone tissue. Mimicking interstitial flow, rather than blood
flow, in the BoPV niche-on-a-chip, led to the formation of stable
and dense vascular networks with capillary-like structures.
However, it is unclear whether these vessels can accommodate
flow. By showing blood vessels perfusability (i.e., introducing
fluorescent dyes), this model will enable the study of additional
steps of the metastatic cascade, including arrest in the blood
stream and extravasation. Notably, perivascular cells expressing
PDGF receptor-β, NG2, or CD146 wrap around the lumens of
capillary-like structures formed by ECs. Mesenchymal stroma is
heterogeneous and it is still debated whether mural cells, such as
pericytes, originate from it. It is likely that, in our model, the
perivascular cells originate from the MSCs. In healthy tissues,
pericytes expressing, among others, specific markers such as
PDGF-Rβ and NG2 are in close contact with ECs to create and
remodel blood vessels. In primary tumors, pericytes act as
gatekeepers against cancer extravasation; however, their role in
cancer metastatic colonization is not clear (20). Early step of
metastasis (intravasation, survival, arrest, extravasation) can be
highly efficient (21). However, only a small subset of cells colo-
nize and form macrometastases. To mimic colonization in the
BoPV niche-on-a-chip, we infused 250 breast cancer cells into
each bone tissue containing more than one million cells. Cancer
cells that successfully engrafted grew readily in the absence of
flow. Importantly, cancer cell proliferation rate decreased four-
fold when exposed to interstitial flow. In contrast with some
reports in the literature (6), in our model ECs have less effect on
the cancer cell growth rate than the MSCs. Because this slow
growth rate could have important implications on the inhibitory
efficacy of small molecules, we studied the drug sensitivity of
cancer cells engrafted in the BoPV niche-on-a-chip. We used
sunitinib, which is an inhibitor of receptor tyrosine kinases that in
breast cancer patients targets the tumor vasculature and pro-
liferative cancer cells. Consistent with other reports, our data
show that sunitinib inhibited breast cancer cell proliferation in
2D culture and in the statically cultured BoPV niche. However,
sunitinib fails to affect slow-proliferative breast cancer cells
disseminated in the BoPV niche-on-a-chip under perfusion,
consistent with data collected in vivo. Studies in mice showed that
sunitinib treatment was effective in inhibiting the primary tumors
but increased the incidence of bone micrometastases (22). Ex-
perimental models and clinical studies both indicate that cancer
stem cells survive many commonly employed anticancer mole-
cules, including sunitinib (23). An attractive hypothesis is that
cancer cells displaying stem cell features can successfully colonize
distant organs and adapt to the changed niche microenvironment.
When exposed to fluid-derived shear forces, oxygen gradients,
stromal cells, and immune cells, these cells may be able to escape
targeted therapy by entering in a slow-proliferative state.
In summary, we synergistically integrated fundamental compo-
nents of the BoPV niche that may play a role in breast cancer
metastatic colonization. Our microfluidic chip, in contrast to most
other microfluidic systems, supports the cultivation of macroscopic
tissues through precisely controlled flow, allowing live assessment
of tissue development and vascularization over long periods of
culture (weeks at the time). By introducing immune cells, tracking
and quantifying their activity, this BoPV niche-on-a-chip could
also become a powerful tool to design and test effective immu-
notherapy strategies in a physiologically relevant context. Model-
ing the early events of metastatic colonization using microfluidic
chips may be useful to identify the key players mediating cancer
latency toward designing more effective therapeutic strategies.
Methods
Cell culture, microfluidic chip, computational modeling, drug studies, and
other standard techniques are described in SI Appendix, SI Methods. For
niche-on-a-chip cultures, ECs expressing RFP were mixed with bone marrow
MSCs and seeded into decellularized bone matrix. The coculture was main-
tained for 1 wk in the EM followed by 1 wk of microfluidic chip culture. After
6 d, MDA-MB-231/GFP or MDA-MB-231/Luc cells were suspended in DMEM
with 1% FBS and 1% penicillin–streptomycin and added to the niche. For
drug studies, 3.5 μM sunitinib was added to the culture. Cancer cell growth
was assessed over 2 wk of culture. Only commercially obtained human cells
were used in the experiments.
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